Tissue Regenix Group Regulatory News (TRX)

9 Dec 2009 09:28



9 December 2009

Oxeco plc

Investing policy update

The Company would like to clarify its investing policy in line with revised AIM Rules for investing companies.

The company's investing policy is as follows:

To invest in companies or projects in the science and technology sectors

To invest through limited liability vehicles including company acquisitions, joint ventures and minority holdings, or where appropriate through the purchase of pure intellectual property

Any such acquisition may be deemed a reverse takeover as per AIM Rule 14

The investment may be passive or active which will be driven by the size of the stake and the Company would like to retain the flexibility to assess this on a case by case basis

The company will not be seeking to define any length of time for any investment nor any target returns at this stage

Update

The Board are continuing to review appropriate targets in the science and technology sectors, however, no specific target has progressed beyond due diligence to date. The Company has £ 2.3 million for the purposes of the investing strategy as defined in the above investing policy. 

For further information, please contact: